U.S. federal trademark · Serial No. 87043574
Radiopharmaceutical imaging and detection agents developed using monoclonal antibodies for diagnosing and monitoring cancer; Diagnostic kits consisting primarily of monoclonal antibodies, and reagents for use in disease testing; Therapeutic pharmaceuticals developed using monoclonal antibodies for the treatment of cancer and other malignancies
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.